Literature DB >> 2818556

Ovalbumin and angiotensinogen lack serpin S-R conformational change.

P E Stein1, D A Tewkesbury, R W Carrell.   

Abstract

Cleavage of ovalbumin and angiotensinogen at sites homologous to the reactive centre loop of alpha 1-antitrypsin is not accompanied by the increase in heat-stability associated with the transition from the native stressed (S) structure to a cleaved relaxed (R) form that is typical of other serpins. Failure to undergo the S-R change in ovalbumin is not due to phosphorylation of Ser-344 near the sites of cleavage on the loop. The suggested explanation is the unique presence of bulky side chains at the P10-P12 site in ovalbumin and angiotensinogen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2818556      PMCID: PMC1133235          DOI: 10.1042/bj2620103

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis.

Authors:  R W Carrell; M C Owen
Journal:  Nature       Date:  1985 Oct 24-30       Impact factor: 49.962

2.  Amino acid sequences containing half-cystine residues in ovalbumin.

Authors:  E O Thompson; W K Fisher
Journal:  Aust J Biol Sci       Date:  1978-10

3.  The complete amino-acid sequence of hen ovalbumin.

Authors:  A D Nisbet; R H Saundry; A J Moir; L A Fothergill; J E Fothergill
Journal:  Eur J Biochem       Date:  1981-04

4.  The amino terminal amino acid sequence of human angiotensinogen.

Authors:  D A Tewksbury; R A Dart; J Travis
Journal:  Biochem Biophys Res Commun       Date:  1981-04-30       Impact factor: 3.575

5.  Ovalbumin is an elastase substrate.

Authors:  H T Wright
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.157

6.  Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence.

Authors:  R Kageyama; H Ohkubo; S Nakanishi
Journal:  Biochemistry       Date:  1984-07-31       Impact factor: 3.162

7.  Phosphorus-31 nuclear magnetic resonance studies of the two phosphoserine residues of hen egg white ovalbumin.

Authors:  H J Vogel; W A Bridger
Journal:  Biochemistry       Date:  1982-11-09       Impact factor: 3.162

8.  Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family.

Authors:  R F Doolittle
Journal:  Science       Date:  1983-10-28       Impact factor: 47.728

9.  Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.

Authors:  H Loebermann; R Tokuoka; J Deisenhofer; R Huber
Journal:  J Mol Biol       Date:  1984-08-15       Impact factor: 5.469

10.  Enzymatic dephosphorylation of ovalbumin and plakalbumin.

Authors:  G E PERLMANN
Journal:  J Gen Physiol       Date:  1952-05       Impact factor: 4.086

View more
  18 in total

1.  Probing the serpin structural-transition mechanism in ovalbumin mutant R339T by proteolytic-cleavage kinetics of the reactive-centre loop.

Authors:  Yasuhiro Arii; Masaaki Hirose
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

2.  Polymerization of human angiotensinogen: insights into its structural mechanism and functional significance.

Authors:  Peter Stanley; Louise C Serpell; Penelope E Stein
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

3.  Suppressors of a host range mutation in the rabbitpox virus serpin SPI-1 map to proteins essential for viral DNA replication.

Authors:  Benjamin G Luttge; Richard W Moyer
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  S-ovalbumin, an ovalbumin conformer with properties analogous to those of loop-inserted serpins.

Authors:  J A Huntington; P A Patston; P G Gettins
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

5.  Evolution of murine alpha 1-proteinase inhibitors: gene amplification and reactive center divergence.

Authors:  C Rheaume; R L Goodwin; J J Latimer; H Baumann; F G Berger
Journal:  J Mol Evol       Date:  1994-02       Impact factor: 2.395

6.  Loop variants of the serpin thyroxine-binding globulin: implications for hormone release upon limited proteolysis.

Authors:  Helmut Grasberger; Henriette M B Golcher; Anja Fingerhut; Onno E Janssen
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

7.  1.45 Å resolution structure of SRPN18 from the malaria vector Anopheles gambiae.

Authors:  David A Meekins; Xin Zhang; Kevin P Battaile; Scott Lovell; Kristin Michel
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-11-19       Impact factor: 1.056

Review 8.  Inhibition of angiogenesis: a new function for angiotensinogen and des(angiotensin I)angiotensinogen.

Authors:  Pierre Corvol; Noel Lamandé; Amauri Cruz; Jerome Celerier; Jean-Marie Gasc
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

9.  Heparin Binds Lamprey Angiotensinogen and Promotes Thrombin Inhibition through a Template Mechanism.

Authors:  Hudie Wei; Haiyan Cai; Jiawei Wu; Zhenquan Wei; Fei Zhang; Xin Huang; Lina Ma; Lingling Feng; Ruoxi Zhang; Yunjie Wang; Hermann Ragg; Ying Zheng; Aiwu Zhou
Journal:  J Biol Chem       Date:  2016-09-28       Impact factor: 5.157

10.  Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.

Authors:  R Zahedi; J J Bissler; A E Davis; C Andreadis; J J Wisnieski
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.